FoxO3 controls cardiomyocyte proliferation and heart regeneration by regulating Sfrp2 expression in postnatal mice

  • 0Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Department of Developmental & Regenerative Biology, College of Life Science and Technology, Jinan University, Guangzhou, 510632, China.

|

|

Summary

This summary is machine-generated.

Forkhead box O3 (FoxO3) deficiency enhances heart repair and regeneration in mice by promoting cardiomyocyte proliferation. This occurs via suppression of secreted frizzled-related protein 2 (Sfrp2) and activation of Wnt/β-catenin signaling.

Area Of Science

  • Cardiovascular Biology
  • Developmental Biology
  • Molecular Cardiology

Background

  • The transcription factor Forkhead box O3 (FoxO3) is vital for adult heart growth.
  • Its precise function in postnatal cardiac repair and regeneration is not fully understood.

Purpose Of The Study

  • To investigate the role of FoxO3 in cardiomyocyte proliferation, cardiac function, and heart regeneration in postnatal mice.
  • To elucidate the molecular mechanisms by which FoxO3 influences cardiac repair.

Main Methods

  • FoxO3 deficiency models in postnatal mice.
  • Assessment of cardiomyocyte proliferation and cardiac function.
  • Analysis of heart regeneration following injury.
  • Investigation of gene expression, including Sfrp2 and Wnt/β-catenin signaling pathways.

Main Results

  • FoxO3 deficiency increased cardiomyocyte proliferation and improved cardiac function in adult mice.
  • Loss of FoxO3 accelerated heart regeneration after injury in both regenerative and non-regenerative stages.
  • FoxO3 directly upregulates secreted frizzled-related protein 2 (Sfrp2) expression, inhibiting Wnt/β-catenin signaling.
  • Sfrp2 overexpression counteracted the pro-regenerative effects of FoxO3 deficiency.

Conclusions

  • FoxO3 acts as a negative regulator of cardiomyocyte proliferation and heart regeneration in postnatal mice.
  • This regulation is mediated, at least in part, through the promotion of Sfrp2 expression and subsequent Wnt/β-catenin pathway inactivation.